Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Myeloid Leukemia Therapy
Researchers at Cornell University, Weill Medical College release new data on acute myeloid leukemia therapy
November 9th, 2008
Fresh data on acute myeloid leukemia are presented in the report 'Arsenic and old lace: novel approaches in elderly patients with acute myeloid leukemia.' "Arsenic has been used for more than 2,000 years in the treatment of a variety of medical conditions, including plague, hysteria, syphilis, and cancer. Numerous potential mechanisms of action have been identified," scientists in the United States report. "Arsenic trioxide has remarkable efficacy in acute promyelocytic leukemia and is approved by the US Food and Drug Administration for this indication. It has also been studied in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and multiple myeloma and has...
Source: Medical Letter on the CDC & FDA (2008-11-09)
|
